Start Date
August 31, 2017
Primary Completion Date
November 1, 2017
Study Completion Date
November 1, 2017
Midodrine
midodrine is metabolized to an active metabolite, desglymidodrine, which is an alpha adrenergic antagonist that causes vasoconstriction of both venous and arterial vasculature, thereby increasing blood pressure
placebo
placebo will be administered to double blind the study
Lead Sponsor
Northwell Health
OTHER